Calibration of PET/CT scanners for multicenter studies on differentiated thyroid cancer with 124I

被引：0
作者：
Jakob W. Kist
Manfred van der Vlies
Otto S. Hoekstra
Henri N. J. M. Greuter
Bart de Keizer
Marcel P. M. Stokkel
Wouter V. Vogel
Marc C. Huisman
Arthur van Lingen
机构：
[1] Netherlands Cancer Institute,Department of Nuclear Medicine
[2] Groene Hart Ziekenhuis,Department of Diagnostics
[3] VU University Medical Center,Department of Radiology and Nuclear Medicine
[4] University Medical Center Utrecht,Department of Nuclear Medicine
来源：
EJNMMI Research | / 6卷
关键词：
Calibration; Multicenter; Quantification; PET/CT; Iodine-124; Differentiated thyroid cancer;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
引用
收藏
相关论文
共 50 条
[21]   The diagnostic value of 124I-PET in patients with differentiated thyroid cancer [J].
Ha T. T. Phan ;
Pieter L. Jager ;
Anne M. J. Paans ;
John T. M. Plukker ;
M. G. G. Sturkenboom ;
W. J. Sluiter ;
Bruce H. R. Wolffenbuttel ;
Rudi A. J. O. Dierckx ;
Thera P. Links .
European Journal of Nuclear Medicine and Molecular Imaging, 2008, 35 :958-965
[22]   124I Positron Emission Tomography/Computed Tomography Versus Conventional Radioiodine Imaging in Differentiated Thyroid Cancer: A Review [J].
Wu, Di ;
Ylli, Dorina ;
Heimlich, S. Layla ;
Burman, Kenneth D. ;
Wartofsky, Leonard ;
Van Nostrand, Douglas .
THYROID, 2019, 29 (11) :1523-1535
[23]   Hard beta and gamma emissions of 124I Impact on occupational dose in PET/CT [J].
Kemerink, G. J. ;
Franssen, R. ;
Visser, M. G. W. ;
Urbach, C. J. A. ;
Halders, S. G. E. A. ;
Frantzen, M. J. ;
Brans, B. ;
Teule, G. J. J. ;
Mottaghy, F. M. .
NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2011, 50 (06) :240-246
[24]   124I-PET dosimetry in advanced differentiated thyroid cancer:: Therapeutic impact [J].
Freudenberg, L. S. ;
Jentzen, W. ;
Goerges, R. ;
Petrich, T. ;
Marlowe, R. J. ;
Knust, J. ;
Bockisch, A. .
NUKLEARMEDIZIN-NUCLEAR MEDICINE, 2007, 46 (04) :121-128
[25]   Identification of a Shine-Through Artifact in the Trachea with 124I PET/CT [J].
Abdul-Fatah, Sakar B. ;
Zamburlini, Mariangela ;
Halders, Serve G. E. A. ;
Brans, Boudewijn ;
Teule, Gerrit J. J. ;
Kemerink, Gerrit J. .
JOURNAL OF NUCLEAR MEDICINE, 2009, 50 (06) :909-911
[26]   Hybrid imaging (SPECT/CT, PET/CT) in differentiated thyroid cancer [J].
Bardet, S. ;
Ciappuccini, R. ;
Aide, N. ;
Barraux, V. ;
Rame, J. -P. .
MEDECINE NUCLEAIRE-IMAGERIE FONCTIONNELLE ET METABOLIQUE, 2010, 34 (08) :457-463
[27]   Multicenter comparison of calibration and cross calibration of PET scanners [J].
Geworski, L ;
Knoop, BO ;
de Wit, M ;
Ivancevic, V ;
Bares, R ;
Munz, DL .
JOURNAL OF NUCLEAR MEDICINE, 2002, 43 (05) :635-639
[28]   PET/CT in the management of differentiated thyroid cancer [J].
Zampella, Emilia ;
Klain, Michele ;
Pace, Leonardo ;
Cuocolo, Alberto .
DIAGNOSTIC AND INTERVENTIONAL IMAGING, 2021, 102 (09) :515-523
[29]   Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer [J].
Walter Jentzen ;
Robert F. Hobbs ;
Alexander Stahl ;
Jochen Knust ;
George Sgouros ;
Andreas Bockisch .
European Journal of Nuclear Medicine and Molecular Imaging, 2010, 37 :884-895
[30]   Pre-therapeutic 124I PET(/CT) dosimetry confirms low average absorbed doses per administered 131I activity to the salivary glands in radioiodine therapy of differentiated thyroid cancer [J].
Jentzen, Walter ;
Hobbs, Robert F. ;
Stahl, Alexander ;
Knust, Jochen ;
Sgouros, George ;
Bockisch, Andreas .
EUROPEAN JOURNAL OF NUCLEAR MEDICINE AND MOLECULAR IMAGING, 2010, 37 (05) :884-895
12345